Show simple item record

dc.contributor.authorBarker, Claire L
dc.contributor.authorSlater, C
dc.contributor.authorBirtle, AJ
dc.date.accessioned2019-11-19T16:00:56Z
dc.date.available2019-11-19T16:00:56Z
dc.date.issued2019en
dc.identifier.citationBarker CL, Slater C, Birtle AJ. A case series of cabazitaxel re-challenge chemotherapy in patients with metastatic castration-resistant prostate cancer who have previously received docetaxel and cabazitaxel chemotherapy. Clin Oncol. 2019.en
dc.identifier.pmid31623896en
dc.identifier.doi10.1016/j.clon.2019.09.051en
dc.identifier.urihttp://hdl.handle.net/10541/622390
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.clon.2019.09.051en
dc.titleA case series of cabazitaxel re-challenge chemotherapy in patients with metastatic castration-resistant prostate cancer who have previously received docetaxel and cabazitaxel chemotherapyen
dc.typeOtheren
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalClinical Oncologyen


Files in this item

This item appears in the following Collection(s)

Show simple item record